Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z6KK
|
|||
| Former ID |
DIB014695
|
|||
| Drug Name |
AZD-5847
|
|||
| Indication | Mycobacterium infection [ICD-11: 1B10-1B21] | Phase 2 | [1] | |
| Company |
AstraZeneca plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01516203) Phase 2a EBA Trial of AZD5847. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.